Laurus Labs
Aarti Drugs to Tata Comm: Earnings rise for 15 firms in Covid-19 economy
Nifty likely to clear the hurdle of 10,850 very soon: Sameet Chavan
Defensive traders should refrain from aggressive bets on Nifty: Nilesh Jain
Laurus Labs under pressure, plunges 10% after multiple block deals
Pharma shares rally; Alembic, Sun Pharma, Laurus Labs hit 52-wk highs

Laurus Labs surges 50% in one month on growth prospects in US market
Patent for Pharmacyclic's cancer drug revoked on challenge by Laurus Labs
Laurus Labs launches generic Lyrica in US to treat neuropathic conditions
Laurus gets USFDA nod for drug that treats malaria, auto-immune disease
Laurus Labs hits record low on disappointing Q1 results

Laurus Labs gets USFDA nod for Visakhapatnam unit
Laurus Labs Q1 net up 51% at Rs 39 cr
Laurus Labs lists at Rs 490, 14% premium against its issue price
Laurus Lab set for stock trading debut from Monday
Laurus Labs' IPO sails through, subscribed 4.5 times
Laurus Labs sets IPO price band at Rs 426-428 per share
 Previous